Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-02-10T04:47:46.843Z Has data issue: false hasContentIssue false

Progressive muscle relaxation as a supportive intervention for cancer patients undergoing chemotherapy: A systematic review

Published online by Cambridge University Press:  28 November 2016

Panagiotis Pelekasis*
Affiliation:
Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
Ifigeneia Matsouka
Affiliation:
Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
Anna Koumarianou
Affiliation:
Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
*
Address correspondence and reprint requests to: Panagiotis Pelekasis, Hematology/Oncology Unit, Fourth Department of Internal Medicine, Attikon Hospital, University of Athens, Rimini 1, 12462 Athens, Greece. E-mail: pelekasispanagiotis@gmail.com.
Rights & Permissions [Opens in a new window]

Abstract

Background:

Many cancer patients use a wide variety of techniques to improve their physical and mental well-being, including relaxation therapy and, specifically, Progressive Muscle Relaxation (PMR). However, there is no strong evidence that supports the efficacy of this technique.

Objective:

Our aim was to review the evidence regarding the use of PMR as a supportive intervention for cancer patients undergoing chemotherapeutic treatment.

Method:

Six databases were electronically searched: AMED, the Cochrane Library, MEDLINE, PsychINFO, Scopus, and the Web of Science. After removing duplicates, 700 publications were screened and 57 identified as potentially relevant. The flow of information from record identification to study inclusion was conducted in accordance with the PRISMA statement. Original articles published in peer-reviewed journals that studied the use of PMR as an intervention, were randomized or included a matched control group, and that included patients receiving chemotherapy were included. Studies that combined PMR with other interventions were excluded. The methodological quality of included trials was assessed using the Jadad Scale and the CONSORT guidelines.

Results:

A total of 5 of the 57 papers fulfilled the preset criteria and were included in our systematic review. Our findings indicate that PMR might improve comfort and reduce the anxiety levels and side effects caused by chemotherapy, with the exception of vomiting. Nonetheless, the quality of all the included studies was extremely low.

Significance of results:

There is evidence that PMR might have a few benefits for patients undergoing chemotherapy. Still, the small number of studies included and their poor quality limit the significance of our results. Despite the fact that pharmaceutical approaches for controlling side effects might be reaching their full potential and that there might be further usefulness for such integrative treatments as PMR, the need to run more high-quality trials testing the efficacy of this technique is warranted before suggesting its adoption as part of standard cancer care.

Type
Review Article
Copyright
Copyright © Cambridge University Press 2016 

INTRODUCTION

Due to its high incidence, cancer poses a major threat to most parts of the developed world, including the European Union, the United States, Canada, Australia, and Japan (Australian Institute of Health and Welfare, 2013; Ferlay et al., Reference Ferlay, Steliarova-Foucher and Lortet-Tieulent2013; Katanoda et al., Reference Katanoda, Hori and Matsuda2015; Kachuri et al., Reference Kachuri, De and Ellison2013; Siegel et al., Reference Siegel, Miller and Jemal2016), while less-developed countries are also threatened by increasing cancer rates (Jemal et al., Reference Jemal, Center and DeSantis2010). A global outburst of this cancer epidemic is expected by 2030, almost doubling new disease cases based on 2008 statistics (Bray et al., Reference Bray, Jemal and Grey2012). Therefore, cancer should be regarded as a worldwide public health hazard.

Thanks to earlier diagnosis and advancements in the field of chemotherapy, this increased incidence has been countered by prolonged survival of cancer patients (DeVita & Chu, Reference DeVita and Chu2008). Nevertheless, patients receiving chemotherapeutic treatment are threatened by such disturbing side effects as nausea and vomiting (Mustian et al., Reference Mustian, Devine and Ryan2011) and cognitive impairment (Moore, Reference Moore2014), as well as such common mental disorders as anxiety, depression, and sleep disorders, triggered by both the disease and the applied therapies (Dickerson et al., Reference Dickerson, Connors and Fayad2014; Die Trill, Reference Die Trill2013; Nakash et al., Reference Nakash, Levav and Aguilar-Gaxiola2014). There is thus an urgent need to intervene in order to address these patients' needs.

Many cancer patients hoping to improve their physical and mental well-being employ complementary and alternative medicine (CAM). Relaxation therapies are one of the most common CAM techniques used (Huebner et al., Reference Huebner, Prott and Micke2014; Molassiotis et al., Reference Molassiotis, Fernandez-Ortega and Pud2005). Most of the patients practicing relaxation therapies start after being diagnosed (Molassiotis et al., Reference Molassiotis, Fernandez-Ortega and Pud2005). Progressive muscle relaxation (PMR) is a CAM intervention (Park et al., Reference Park2013) that includes repetitive cycles of tensing and relaxing of major muscle groups combined with breathing exercises (Jacobson, Reference Jacobson1938).

Regarding the effect of PMR in noncancer patient populations, there is evidence from several systematic reviews suggesting that it is an effective technique. For example, it has been shown to decrease elevated blood pressure (Rainforth et al., Reference Rainforth, Schneider and Nidich2007), to manage the pain of osteoarthritis (Morone & Greco, Reference Morone and Greco2007), and to improve the mental state and subjective well-being of persons suffering from schizophrenia (Vancampfort et al., Reference Vancampfort, Correll and Scheewe2013). Additionally, PMR has demonstrated efficacy in decreasing depressive and anxiety symptoms in the general population (Jorm et al., Reference Jorm, Morgan and Hetrick2008; Manzoni et al., Reference Manzoni, Pagnini and Castelnuovo2008).

To date, the effects of this intervention on cancer patients receiving chemotherapy have been reported in a few sporadic publications. A recent case study found that the development of panic disorder in a 54-year-old breast cancer patient receiving eight cycles of adjuvant chemotherapy was blocked by the practice of PMR (Koumarianou et al., Reference Koumarianou, Pelekasis and Kontogoni2015). According to a bold study comparing two different interventions to counter anxiety and depression, the efficacy of PMR was found to be almost equivalent to receiving 0.5 mg of the triazolobenzodiazepine alprazolam three times daily (Holland et al., Reference Holland, Morrow and Schmale1991). Despite these data, the appropriate way to come to a conclusion about a treatment's efficacy is to test an intervention condition against a control by applying a randomized trial, or even by using well-formulated and matched subject groups (Robson, Reference Robson2002).

The present study evaluates the efficacy of PMR in improving the mental and physical well-being of cancer patients receiving chemotherapeutic treatment by reviewing all the relevant PMR trials.

METHODS

Registration

Our systematic review was registered in the PROSPERO database (registration no. CRD42016043111). There were no violations of the original protocol during any stages of the research.

Literature Search

All three authors participated in the literature search process. A search for English-language papers published from January of 1990 until July 3, 2016 was carried out in AMED, the Cochrane Library, MEDLINE, PsychINFO, Scopus, and the Web of Science databases. The combinations utilized were “progressive muscle relaxation” AND (cancer OR oncology OR chemotherapy). In addition, a snowball technique was employed in order to include any potential studies not revealed through this process. Issues of related journals, reference lists of included studies, and other relevant papers in the field were rummaged through in an attempt to locate possible records. The flow of information from record identification to inclusion followed the principles of the PRISMA statement (Moher et al., Reference Moher, Liberati and Tetzlaff2009).

Study Selection

Regarding study selection, the inclusion criteria were as follows: (1) original articles published in peer-reviewed journals; (2) two-arm trials with matched or randomized intervention and control groups; (3) using only PMR as an intervention; and (4) including cancer patients currently receiving chemotherapeutic treatment. The exclusion criteria were as follows: studies combining PMR with other interventions (e.g., psychoeducation). Identified abstracts were stored using Zotero reference management software. All authors participated in the study selection process.

Data Extraction

The extracted data from these papers included: study authors, country, total number of patients, patient gender, primary tumor, duration of PMR sessions, duration of the intervention, frequency of practice, average adherence rate, follow-up, variables examined, measures used, main findings, and qualitative reports.

The quality of trials was estimated by using the Jadad Scale and the CONSORT guidelines. The Jadad Scale is a brief (score range = 0–5 points) instrument used to rate the quality of a trial (Jadad et al., Reference Jadad, Moore and Carroll1996). Randomization and double blinding were given two points each, while reporting withdrawal and dropout reasons received a single point. The CONSORT statement is a checklist including a variety of items concerning the quality of each separate section of a published trial (Schulz et al., Reference Schulz, Altman and Moher2010) (see Appendix I).

Both the data extraction process and trial evaluation were carried out by the first author and crosschecked by the second author. Disagreements were resolved through discussion or with the help of the third author.

RESULTS

The literature search conducted led to 700 unique potentially relevant records, of which 643 were not searched since their title was irrelevant to the scope of the specific systematic review, so that 57 abstracts were accessed.

As for the 57 studies whose abstracts were accessed, most did not meet the eligibility criteria of the systematic review: 4 were not in peer-reviewed journal publications, 14 used PMR along with another intervention, 11 included no cancer- nor chemotherapy-related populations, 21 were not two-armed trials with matched or randomized intervention and control groups, and 2 did not use PMR as an intervention. Therefore, five studies were finally included in our systematic review (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010; Song et al., Reference Song, Xu and Zhang2013; Yilmaz & Arslan, Reference Yilmaz and Arslan2015). The information flowchart is depicted in Figure 1.

Fig. 1. Information flowchart

Four of these studies were randomized controlled trials (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Demiralp, Reference Demiralp, Oflaz and Komurcu2010; Yilmaz & Arslan, Reference Yilmaz and Arslan2015), while one used matched subjects (Song et al., Reference Song, Xu and Zhang2013). The participants in all studies were measured at baseline, those in the intervention group were provided with a PMR session practiced during the full length of follow-up, and all were measured during an endpoint assessment. In total, 255 patients were analyzed. Apart from the large range of sample sizes (8–100), there was also a discrepancy across studies regarding their specific characteristics (e.g., the measures used). These characteristics are detailed in Table 1.

Table 1. Extracted data

N = number of patients; NA = not applicable; PMR = progressive muscle relaxation; STAI = State–Trait Anxiety Inventory.

The quality of trials was found to be low since four out of five of the studies were given a rating of zero points on the Jadad Scale (Arakawa, Reference Arakawa1997; Demiralp, Reference Demiralp, Oflaz and Komurcu2010; Song et al., Reference Song, Xu and Zhang2013; Yilmaz & Arslan, Reference Yilmaz and Arslan2015), while one was rated 1 due to reporting of participants' reasons for dropping out (Arakawa, Reference Arakawa1995). The appraisal using the CONSORT guidelines also found a low trial quality (see Appendix I). As indicated, there were several weak points, such as not describing the mechanism used to implement random allocation and research blinding (in all trials) and sample size determination (in four of five trials).

Due to the small number of included studies, their small sample sizes, and their heterogeneity regarding several characteristics (tumor type, gender, measures used, and outcomes assessed), pooling of results was not considered to be a wise option. Thus, all five eligible studies are presented narratively in the following section.

Summaries of Included Studies

Arakawa (Reference Arakawa1995) examined the effects of PMR in a sample with various primary tumors. Sessions included tense/release of 16 muscle groups and deep breathing (for a total of 15 minutes) twice a day. Anxiety and side effects were recorded before and after chemotherapy using the State–Trait Anxiety Inventory (STAI) and the Morrow Assessment of Nausea and Emesis, respectively. Eight patients completed the endpoint assessments. The average adherence rate of the practice reached 98%, recorded by the investigator through direct observation of each individual practicing the technique once a day. The frequency and duration of nausea and state anxiety were decreased in the intervention group, while vomiting and trait anxiety were unaffected. With regard to self-reports in that group, they recounted being able to eat more and maintain a more optimal mobility level at the last chemotherapy session compared to the previous one.

The second trial (Arakawa, Reference Arakawa1997) tested the effectiveness of the same intervention in a larger sample of patients (N = 60) diagnosed with different tumor types and receiving a variety of different chemotherapeutic agents and antiemetics. Intervention group participants were advised to practice a 25-minute PMR session twice a day, while control group participants were contacted for 10–15 minutes daily in an attempt to equalize the placebo effect. The average adherence rate reached 85.8%, recorded by the investigator through direct observation of each individual practicing the technique once a day. Assessments were carried out one week before initiation of their initial course and 72 hours after receiving the standard chemotherapy treatment. As measured by the STAI and the Rhodes Index of Nausea and Vomiting–Form 2, both scores were significantly reduced in the intervention group. However, subscale analyses indicated that vomiting was not significantly decreased, possibly due to the extremely low incidence in both groups.

The third study (Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010) reported a prospective repeated-measures randomized trial with 27 total participants (intervention group, n = 14; control group, n = 13). Patients in the intervention group were assigned a 25- to 30-minute PMR session and were advised to practice this technique on a daily basis. Four repeated measures from day 1 until day 90 after the beginning of chemotherapy were used. The Pittsburgh Sleep Quality Index and the Piper Fatigue Scale (PFS) were utilized to measure sleep quality and fatigue, respectively. The results indicated that overall sleep was improved in the third and fourth measurements and that several subcomponents of sleep quality (e.g., habitual sleep efficiency) were improved in some post-intervention measurements. Similarly, the PFS score was also reduced in the intervention group (p = 0.014).

The fourth study (Song et al., Reference Song, Xu and Zhang2013) examined the effects of PMR on 100 female breast cancer patients receiving chemotherapy. Patients were divided into two equal-sized groups matched by age, level of education, and tumor stage. The STAI, the Rotterdam Symptom Scale, and self-reported symptoms were employed to assess severity of anxiety, cancer discomfort, and chemotherapy-related symptoms, respectively (loss of appetite, lack of energy, nausea, acid reflux, mouth ulcers, cough, and back pain). All of these scores were significantly lower in the intervention group after practicing the technique.

The final trial (Yilmaz & Arslan, Reference Yilmaz and Arslan2015) examined the effects of the technique on 30 experimental and 30 control patients. The intervention group took part in four supervised sessions and were provided with a CD to help them practice the technique on their own three times a week, as suggested. The pre- and posttest outcomes were anxiety (measured by the STAI) and cancer discomfort (assessed by the General Comfort Questionnaire). While patients did not differ regarding these variables at baseline, both anxiety (p > 0.0001) and general comfort (p > 0.0001) were reduced in the intervention group after practicing the technique.

DISCUSSION

The present systematic review is the first study in the literature that clearly focuses on the effect of PMR in cancer patients undergoing chemotherapy. Its findings indicate that this technique may decrease a variety of side effects (including nausea), improve sleep quality, reduce anxiety levels, and provide a few additional episodic benefits (e.g., amelioration of diet) (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010; Song et al., Reference Song, Xu and Zhang2013; Yilmaz & Arslan, Reference Yilmaz and Arslan2015). Three of the included studies concerned breast cancer patients (Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010; Song et al., Reference Song, Xu and Zhang2013; Yilmaz & Arslan, Reference Yilmaz and Arslan2015), while the other two looked at mixed cancer populations (Arakawa, Reference Arakawa1995; Reference Arakawa1997). As indicated in Table 1, with the exception of the STAI being used in three trials (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Yilmaz & Arslan, Reference Yilmaz and Arslan2015), there was heterogeneity of self-reporting tools, which resulted in no directly comparable results. Apart from the study by Song et al. (Reference Song, Xu and Zhang2013), in which 100 patients were included, the remaining studies had a relatively small sample size (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010; Yilmaz & Arslan, Reference Yilmaz and Arslan2015). Even though extracting data from available trials is important, it could be considered worthless if this evidence is not further analyzed. In that context, several parameters of the specific systematic review results are narratively discussed in the following subsections.

Feasibility

As reported in the studies included in our systematic review, PMR has been shown to be a feasible intervention. Participant adherence was measured in only two of the included trials, where the average adherence rates were 98 and 85.8%, respectively (Arakawa, Reference Arakawa1995; Reference Arakawa1997). The high adherence rates reported could be attributed to the cultural characteristics of the patients included in those two trials, which could influence adherence to health professionals' guidelines. In addition, the high acceptance of CAM therapies by cancer patients in Japan might have influenced this high adherence rate (Eguchi et al., Reference Eguchi, Hyodo and Saeki2000; Hyodo et al., Reference Hyodo, Amano and Eguchi2005). As to adverse events, no side effects related or possibly caused by practicing PMR were reported in any of the included trials (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010; Song et al., Reference Song, Xu and Zhang2013; Yilmaz & Arslan, Reference Yilmaz and Arslan2015). Even though there is no solid evidence from well-designed clinical studies that practicing PMR has its hindrances, it is logical to assume that the absence of side effects and the relatively high adherence rate make PMR a feasible intervention for cancer patients undergoing chemotherapeutic treatment.

Comparison with Similar Scoping Interventions

The evidence of our paper highlights the potential efficacy of PMR in countering anxiety and some chemotherapy-related side effects. Even though advanced pharmacological approaches have tackled the huge impact of nausea and vomiting, these side effects remain a major problem in cancer care (Glare et al., Reference Glare, Miller and Nikolova2011; Kamen et al., Reference Kamen, Tejani and Chandwani2014). Such nonpharmacological interventions as acupuncture and acupressure may also play a role in moderating these side effects (Garcia et al., Reference Garcia, McQuade and Haddad2013; Roscoe et al., Reference Roscoe, Morrow and Hickok2003). Compared to these techniques, PMR has the advantages of benefiting both the physical and mental well-being of patients and that it can be easily practiced with the aid of playing a CD at home, without requiring extra visits with another health professional.

The comparison of the effect of PMR as opposed to other interventions has been explored by few studies to date. One such study compared the efficacy of PMR and music therapy (Lee et al., Reference Lee, Bhattacharya and Sohn2012). Yet, these studies have been excluded from specific systematic reviews whose purpose was to compare the efficacy of PMR and usual care. The comparison of an intervention with usual care is a one-way matter when searching for the effect of interventions that are not part of usual care practices (Thompson & Schoenfeld, Reference Thompson and Schoenfeld2007). Since the purpose of our study was to evaluate the efficacy of PMR compared to usual care, any comparison with another intervention should be part of other analyses.

External and Internal Validity

The five identified studies were conducted in three different countries (Japan, China, and Turkey), thus involving patients with different cultural backgrounds, nationalities, religions, and access to healthcare facilities (Arakawa, Reference Arakawa1995; Reference Arakawa1997; Demiralp et al., Reference Demiralp, Oflaz and Komurcu2010; Song et al., Reference Song, Xu and Zhang2013; Yilmaz & Arslan, Reference Yilmaz and Arslan2015). In addition, both of Arakawa's studies (Reference Arakawa1995; Reference Arakawa1997) included patients with several types of common cancers (e.g., lung, colorectal, breast), thus forming an inhomogeneous sample quite representative of the general cancer population. For these reasons, the external validity of the results of our systematic review should be considered to be relatively high. In contrast, its level of internal validity is in doubt due to the low trial quality (as indicated by both the Jadad Scale and the CONSORT criteria), thus raising concerns about the reliability of the reported efficacy. The main problem with the internal validity of all the included studies is a lack of specific information about patient randomization. Also, no patients nor outcome investigators were blinded in any of these studies. In addition, sample size estimation was carried out only in one trial (Yilmaz & Arslan, Reference Yilmaz and Arslan2015). Since most study samples were small, this could lead to type I error. Hence, the internal validity of the studies included in our systematic review is fairly low.

Implications for Further Research

The small number of included studies indicates that there is a need for more extensive research regarding the effect of PMR on patients undergoing chemotherapeutic treatment. Although many trials were found that employed PMR as an adjunct to chemotherapy, the majority combined PMR with other interventions. Another minor category included studies that applied different PMR relaxation techniques. There is an urgent need to design clinical trials that could establish the role of PMR as a single nonpharmacological intervention to improve the well-being of cancer patients receiving chemotherapy.

In addition, there is a need for higher methodological quality. It is of concern that all except one study scored zero points on the Jadad Scale. The main reason for this failure arose from the difficulty in blinding patients who received the intervention. A major challenge for every CAM intervention is to establish its effects through a placebo-controlled trial (Lewith, Reference Lewith2002). Such trials pose serious obstacles to research on the effect of such CAM interventions as magnetic therapy (Carpenter et al., Reference Carpenter, Wells and Lambert2002), while other interventions (e.g., acupressure) have successfully passed this test (Roscoe et al., Reference Roscoe, Morrow and Hickok2003).

In the case of PMR, sham sessions could be constructed by teaching participants to inhale and exhale at a usual pace and continuously repeating an exercise—such as tensing the same muscle or making any other body part move, instead of tensing all muscle groups one by one. The same timeframe for PMR sessions would also be essential. This type of pseudo-session is based on the philosophy of the placebo needle employed in acupuncture research (Streitberger & Kleinhenz, Reference Streitberger and Kleinhenz1998) and could possibly lead to effective patient blinding.

Consonance with Recent Trends in Cancer Care

A growing body of literature focuses on how to transform traditional healthcare delivery into an more integrative process, resulting in a model where both conventional and CAM therapies are applied aimed at improving and promoting the patient's mental and physical health (Maizes et al., Reference Maizes, Rakel and Niemiec2009). Cancer care should not be unaffected by this trend. To date, there are only a few studies that combine and test the use of different conventional techniques together with CAM interventions, including PMR, on patients receiving chemotherapy (Mahendran et al., Reference Mahendran, Lim and Tan2015; Pelekasis et al., Reference Pelekasis, Zisi and Koumarianou2016). Since these programs aim to prove that they are clinically applicable, the background of their interventions must be extremely solid, meaning that each of the techniques under study must have proven benefits for patients. Thus, intensifying the research on the effects of PMR would not only benefit the reliability of this technique but also that of integrative cancer care programs that include PMR as part of their interventional regimen.

CONCLUSIONS

Preliminary results on PMR have shown that this method tackles anxiety and improves some of the side effects caused by chemotherapy (e.g., nausea, fatigue). Nonetheless, due to the limited number of studies and their low quality, it is premature to strongly support these statements and suggest the adoption of PMR as part of standard cancer care. The technique deserves further investigation in the context of randomized controlled trials.

CONFLICTS OF INTEREST

The authors hereby state that they have no potential conflicts of interest to declare.

FUNDING

This research received no specific grants from any funding agency in either the public, commercial, or not-for-profit sector.

SUPPLEMENTARY MATERIALS AND METHODS

To view supplementary material for this article, please visit https://doi.org/10.1017/S1478951516000870.

References

REFERENCES

Arakawa, S. (1995). Use of relaxation to reduce side effects of chemotherapy in Japanese patients. Cancer Nursing, 18(1), 6066.CrossRefGoogle ScholarPubMed
Arakawa, S. (1997). Relaxation to reduce nausea, vomiting, and anxiety induced by chemotherapy in Japanese patients. Cancer Nursing, 20(5), 342349.CrossRefGoogle ScholarPubMed
Australian Institute of Health and Welfare (2013). Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012. Asian Pacific Journal of Clinical Oncology, 9(3), 199213. Available from http://onlinelibrary.wiley.com/doi/10.1111/ajco.12127/pdf.CrossRefGoogle Scholar
Bray, F., Jemal, A., Grey, N., et al. (2012). Global cancer transitions according to the Human Development Index (2008–2030): A population-based study. The Lancet. Oncology, 13(8), 790801.CrossRefGoogle Scholar
Carpenter, J.S., Wells, N., Lambert, B., et al. (2002). A pilot study of magnetic therapy for hot flashes after breast cancer. Cancer Nursing, 25(2), 104109.CrossRefGoogle ScholarPubMed
Demiralp, M., Oflaz, F. & Komurcu, S. (2010). Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy. Journal of Clinical Nursing, 19(8), 10731083.CrossRefGoogle ScholarPubMed
DeVita, V.T. Jr. & Chu, E. (2008). A history of cancer chemotherapy. Cancer Research, 68(21), 86438653. Available from http://cancerres.aacrjournals.org/content/68/21/8643.long.CrossRefGoogle ScholarPubMed
Dickerson, S.S., Connors, L.M., Fayad, A., et al. (2014). Sleep–wake disturbances in cancer patients: Narrative review of literature focusing on improving quality of life outcomes. Nature and Science of Sleep, 6, 85100. Epub ahead of print Jul 12. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4103930/.CrossRefGoogle ScholarPubMed
Die Trill, M. (2013). Anxiety and sleep disorders in cancer patients. EJC Supplements, 11(2), 216224. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041166/.CrossRefGoogle ScholarPubMed
Eguchi, K., Hyodo, I. & Saeki, H. (2000). Current status of cancer patients' perception of alternative medicine in Japan: A preliminary cross-sectional survey. Supportive Care in Cancer, 8(1), 2832.CrossRefGoogle ScholarPubMed
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., et al. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), 13741403. Epub ahead of print Feb 26. Available from http://www.ejcancer.com/article/S0959-8049(13)00007-5/pdf.CrossRefGoogle ScholarPubMed
Garcia, M.K., McQuade, J., Haddad, R., et al. (2013). Systematic review of acupuncture in cancer care: A synthesis of the evidence. Journal of Clinical Oncology, 31(7), 952960. Epub ahead of print Jan 22. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577953/.CrossRefGoogle Scholar
Glare, P., Miller, J., Nikolova, T., et al. (2011). Treating nausea and vomiting in palliative care: A review. Clinical Interventions in Aging, 6(), 243259. Epub ahead of print Sep 12. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180521/.CrossRefGoogle ScholarPubMed
Holland, J.C., Morrow, G.R., Schmale, A., et al. (1991). A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. Journal of Clinical Oncology, 9(6), 10041011.CrossRefGoogle ScholarPubMed
Huebner, J., Prott, F.J., Micke, O., et al. (2014). Online survey of cancer patients on complementary and alternative medicine. Oncology Research and Treatment, 37(6), 304308. Epub ahead of print May 12. Available from http://www.karger.com/Article/FullText/362616.CrossRefGoogle ScholarPubMed
Hyodo, I., Amano, N., Eguchi, K., et al. (2005). Nationwide survey on complementary and alternative medicine in cancer patients in Japan. Journal of Clinical Oncology, 23(12), 26452654. Available from http://ascopubs.org/doi/pdf/10.1200/jco.2005.04.126.CrossRefGoogle ScholarPubMed
Jacobson, E. (1938). Progressive relaxation. Chicago: University of Chicago Press.Google Scholar
Jadad, A.R., Moore, R.A., Carroll, D., et al. (1996). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 17(1), 112.CrossRefGoogle ScholarPubMed
Jemal, A., Center, M.M., DeSantis, C., et al. (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers & Prevention, 19(8), 18931907. Epub ahead of print Jul 20. Available from http://cebp.aacrjournals.org/content/19/8/1893.long.CrossRefGoogle ScholarPubMed
Jorm, A.F., Morgan, A.J. & Hetrick, S.E. (2008). Relaxation for depression. The Cochrane Database of Systematic Reviews, (4), CD007142.CrossRefGoogle ScholarPubMed
Kachuri, L., De, P., Ellison, L.F., et al. (2013). Cancer incidence, mortality and survival trends in Canada, 1970–2007. Chronic Diseases and Injuries in Canada, 33(2), 6980. Available from http://www.phac-aspc.gc.ca/publicat/hpcdp-pspmc/33-2/ar-03-eng.php.CrossRefGoogle ScholarPubMed
Kamen, C., Tejani, M.A., Chandwani, K., et al. (2014). Anticipatory nausea and vomiting due to chemotherapy. European Journal of Pharmacology, 722, 172179. Epub ahead of print Oct 21, 2013. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880638/.CrossRefGoogle ScholarPubMed
Katanoda, K., Hori, M., Matsuda, T., et al. (2015). An updated report on the trends in cancer incidence and mortality in Japan, 1958–2013. Japanese Journal of Clinical Oncology, 45(4), 390401. Epub ahead of print Jan 30. Available from http://jjco.oxfordjournals.org/content/45/4/390.full.pdf+html.CrossRefGoogle ScholarPubMed
Koumarianou, A., Pelekasis, P., Kontogoni, M., et al. (2015). How to encounter the development of panic disorder during adjuvant breast cancer chemotherapy: A case study. Journal of Clinical Case Reports, 4, 475. Available from http://www.omicsgroup.org/journals/how-to-encounter-the-development-of-panic-disorder-during-adjuvant-breast-cancer-2165-7920.1000475.pdf.php?aid=40666.Google Scholar
Lee, E.J., Bhattacharya, J., Sohn, C., et al. (2012). Monochord sounds and progressive muscle relaxation reduce anxiety and improve relaxation during chemotherapy: A pilot EEG study. Complementary Therapies in Medicine, 20(6), 409416. Epub ahead of print 2012 Aug 23. Available from http://www.complementarytherapiesinmedicine.com/article/S0965-2299(12)00088-X/pdf.CrossRefGoogle ScholarPubMed
Lewith, G.T. (2002). Clinical research in complementary therapies: Principles, problems and solutions. Edinburgh: Churchill Livingstone.Google Scholar
Mahendran, R., Lim, H.A., Tan, J.Y., et al. (2015). Efficacy of a brief nurse-led pilot psychosocial intervention for newly diagnosed Asian cancer patients. Supportive Care in Cancer, 23(8), 22032206. Epub ahead of print May 23.CrossRefGoogle ScholarPubMed
Maizes, V., Rakel, D. & Niemiec, C. (2009). Integrative medicine and patient-centered care. Explore (New York, N.Y.), 5(5), 277289.CrossRefGoogle ScholarPubMed
Manzoni, G.M., Pagnini, F., Castelnuovo, G., et al. (2008). Relaxation training for anxiety: A ten-years systematic review with meta-analysis. BMC Psychiatry, 8, 41. Available from https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2427027/.CrossRefGoogle ScholarPubMed
Moher, D., Liberati, A., Tetzlaff, J., et al. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6, e1000097. Epub ahead of print Jul 21. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707599/.CrossRefGoogle ScholarPubMed
Molassiotis, A., Fernandez-Ortega, P., Pud, D., et al. (2005). Use of complementary and alternative medicine in cancer patients: A European survey. Annals of Oncology, 16(4), 655663. Epub ahead of print Feb 2. Available from http://annonc.oxfordjournals.org/content/16/4/655.full.pdf+html.CrossRefGoogle ScholarPubMed
Moore, H.C. (2014). An overview of chemotherapy-related cognitive dysfunction, or “chemobrain.” Oncology (Williston Park, N.Y.), 28(9), 797804. Available from http://www.cancernetwork.com/oncology-journal/overview-chemotherapy-related-cognitive-dysfunction-or-chemobrain.Google ScholarPubMed
Morone, N.E. & Greco, C.M. (2007). Mind–body interventions for chronic pain in older adults: A structured review. Pain Medicine (Malden, Mass.), 8(4), 359375. Available from http://painmedicine.oxfordjournals.org/content/8/4/359.long.CrossRefGoogle ScholarPubMed
Mustian, K.M., Devine, K., Ryan, J.L., et al. (2011). Treatment of nausea and vomiting during chemotherapy. U.S. Oncology & Hematology, 7(2), 9197. Available from https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3898599/.Google ScholarPubMed
Nakash, O., Levav, I., Aguilar-Gaxiola, S., et al. (2014). Comorbidity of common mental disorders with cancer and their treatment gap: Findings from the World Mental Health Surveys. Psycho-Oncology, 23(1), 4051. Epub ahead of print Aug 27, 2013. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992888/.CrossRefGoogle ScholarPubMed
Park, C. (2013). Mind–body CAM interventions: Current status and considerations for integration into clinical health psychology. Journal of Clinical Psychology, 69(1), 4563. Epub ahead of print Aug 30, 2012.CrossRefGoogle ScholarPubMed
Pelekasis, P., Zisi, G., Koumarianou, A., et al. (2016). Forming a stress management and health promotion program for women undergoing chemotherapy for breast cancer: A pilot randomized controlled trial. Integrative Cancer Therapies, 15(2), 165174. Epub ahead of print Aug 4, 2015. Available from http://ict.sagepub.com/content/15/2/165.long.CrossRefGoogle ScholarPubMed
Rainforth, M.V., Schneider, R.H., Nidich, S.I., et al. (2007). Stress reduction programs in patients with elevated blood pressure: A systematic review and meta-analysis. Current Hypertension Reports, 9(6), 520528. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268875/.CrossRefGoogle ScholarPubMed
Robson, C. (2002). Real-world research: A resource for social scientists and practitioner-researchers, 2nd ed. Malden, MA: Blackwell Publishing.Google Scholar
Roscoe, J.A., Morrow, G.R., Hickok, J.T., et al. (2003). The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting: A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. Journal of Pain and Symptom Management, 26(2), 731742. Available from http://www.jpsmjournal.com/article/S0885-3924(03)00254-9/pdf.CrossRefGoogle ScholarPubMed
Schulz, K.F., Altman, D.G., Moher, D., et al. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine, 152(11), 726732. Epub ahead of print Mar 24. Available from http://annals.org/aim/article/745807/consort-2010-statement-updated-guidelines-reporting-parallel-group-randomized-trials.CrossRefGoogle ScholarPubMed
Siegel, R.L., Miller, K.D. & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 730. Epub ahead of print Jan 7. Available from http://onlinelibrary.wiley.com/doi/10.3322/caac.21332/full.Google Scholar
Song, Q.H., Xu, R.M., Zhang, Q.H., et al. (2013). Relaxation training during chemotherapy for breast cancer improves mental health and lessens adverse events. International Journal of Clinical and Experimental Medicine, 6(10), 979984. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832338/.Google ScholarPubMed
Streitberger, K. & Kleinhenz, J. (1998). Introducing a placebo needle into acupuncture research. Lancet, 352(9125), 364365.CrossRefGoogle ScholarPubMed
Thompson, B.T. & Schoenfeld, D. (2007). Usual care as the control group in clinical trials of nonpharmacologic interventions. Proceedings of the American Thoracic Society, 4(7), 577582. Available from https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2647648/.CrossRefGoogle Scholar
Vancampfort, D., Correll, C.U. & Scheewe, T.W. (2013). Progressive muscle relaxation in persons with schizophrenia: A systematic review of randomized controlled trials. Clinical Rehabilitation, 27(4), 291298. Epub ahead of print Jul 27, 2012.CrossRefGoogle ScholarPubMed
Yilmaz, S.G. & Arslan, S. (2015). Effects of progressive relaxation exercises on anxiety and comfort of Turkish breast cancer patients receiving chemotherapy. Asian-Pacific Journal of Cancer Prevention, 16(1), 217220. Available from http://journal.waocp.org/article_30416_298f0f99a9d472a5672cfad505f03a6e.pdf.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Information flowchart

Figure 1

Table 1. Extracted data

Supplementary material: File

Pelekasis supplementary material

CONSORT Checklist

Download Pelekasis supplementary material(File)
File 37.3 KB